Simian adenovirus nucleic acid and amino acid sequences, vectors containing same, and methods of use

Details for Australian Patent Application No. 2002365366 (hide)

Owner The Trustees of the University of Pennsylvania

Inventors Roy, Soumitra; Wilson, James M; Gao, Guangping

Agent Davies Collison Cave

Pub. Number AU-B-2002365366

PCT Number PCT/US02/33645

PCT Pub. Number WO2003/046124

Priority 60/366,798 22.03.02 US; 60/331,951 21.11.01 US

Filing date 20 November 2002

Wipo publication date 10 June 2003

Acceptance publication date 10 May 2007

International Classifications

C12N 15/09 (2006.01) Mutation or genetic engineering - Recombinant DNA-technology

A61K 39/00 (2006.01) Medicinal preparations containing antigens or antibodies

A61K 48/00 (2006.01) Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases

A61P 37/04 (2006.01) Drugs for immunological or allergic disorders

A61P 43/00 (2006.01) Drugs for specific purposes, not provided for in groups

C07K 14/025 (2006.01) Peptides having more than 20 amino acids

C07K 14/075 (2006.01) Peptides having more than 20 amino acids

C07K 14/08 (2006.01) Peptides having more than 20 amino acids

C07K 14/145 (2006.01) Peptides having more than 20 amino acids

C07K 14/16 (2006.01) Peptides having more than 20 amino acids

C12N 1/15 (2006.01) Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 1/19 (2006.01) Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 1/21 (2006.01) Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 5/10 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines - Cells modified by introduction of foreign genetic material, e.g. virus-transformed cells

C12N 7/00 (2006.01) Viruses, e.g. bacteriophages

C12N 7/04 (2006.01) Viruses, e.g. bacteriophages - Inactivation or attenuation

C12N 15/33 (2006.01) Mutation or genetic engineering - Genes encoding viral proteins

C12N 15/861 (2006.01) Mutation or genetic engineering - Adenoviral vectors

C12P 21/02 (2006.01) Preparation of peptides or proteins - having a known sequence of two or more amino acids, e.g. glutathione

Event Publications

14 August 2003 Complete Application Filed

  Priority application(s): 60/366,798 22.03.02 US; 60/331,951 21.11.01 US

21 August 2003 Application Open to Public Inspection

  Published as AU-B-2002365366

10 May 2007 Application Accepted

  Published as AU-B-2002365366

6 September 2007 Standard Patent Sealed

10 July 2008 Licence Registered

  The Trustees of the University of Pennsylvania ( SmithKline Beecham Corporation d/b/a GlaxoSmithKline )

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002365367-METHOD AND SYSTEM FOR PRODUCING A POTENTIAL OVER A BODY

2002365365-METAL COMPLEX COMPOUNDS